Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the way new mothers with chronic health conditions, such as high blood pressure, diabetes, anxiety, and obesity, receive care after giving birth. Many new mothers struggle to connect with their primary care doctors, which can make managing their health more difficult. The study is testing a new approach to help these mothers transition from hospital care to regular doctor visits more smoothly, using supportive methods based on understanding how people make decisions about their health. By doing this, the researchers hope to encourage ongoing medical care that helps mothers stay healthy for themselves and their families.
To be eligible for the trial, participants need to be at least 18 years old, and they should be receiving care at a specific hospital practice. They must be pregnant or have recently given birth to a healthy baby and have one or more of the targeted chronic conditions, like diabetes or high blood pressure. Participants will have access to their medical records online and will be involved in regular check-ins for feedback throughout the study. This trial is not yet recruiting participants, but it aims to set a new standard for postpartum care that could benefit many women in the future.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria
- • Receiving obstetric care at an MGH-affiliated obstetrics practice (except for the MGH HOPE Clinic, which has a unique care model that provides prenatal and postnatal care for individuals with substance use disorder, including the provision of primary care through 2+ years postpartum)
- • Pregnant with a live fetus or delivered a live-born neonate ≥24 weeks of gestation, based on the clinical estimate of gestational age
- • If postpartum, has a neonate that is currently living at the time of enrollment
- * Has one or more of the following conditions listed in the "Problem List," "Medical History," or clinical notes during prenatal, intrapartum, or postpartum encounters in the EHR (or in the case of BMI, the patient's anthropometric measurements):
- • Chronic or essential hypertension
- • Hypertensive disorders related to pregnancy (e.g., pre-eclampsia)
- • Type 1 or 2 diabetes (i.e., pre-existing diabetes)
- • Gestational diabetes
- • Class II Obesity (pre-pregnancy body mass index ≥35 kg/m2; or if pre-pregnancy body mass index is not known, a first trimester BMI of ≥35 kg/m2)
- • Depression or anxiety disorder
- • Has a primary care clinician listed in the patient's medical record
- • Has access to or agrees to be enrolled in the electronic health record patient portal and consents to be contacted via these modalities
- • Able to read/speak English or Spanish language
- • Is age ≥18 years old
- • Exclusion Criteria
- • • Any individual not meeting all inclusion criteria
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Mark A Clapp, MD, MPH
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported